Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Resources>Application Notes>This Application Note
  Application Notes
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Combination Drug Therapy Shrinks Pancreatic Tumors In Mice
Two drugs that affect the structure and function of DNA have been found to block the growth of pancreatic tumor cells in mice, researchers hope the drugs can soon be tested in humans with the disease.
Seeking A Better Way To Design Drugs
NIH funds research at Worcester Polytechnic Institute to advance a new chemical process for more effective drug development and manufacturing.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Diabetes Drugs May Actually Release Sugar Into the Blood
A family of drugs used to treat Type 2 diabetes could promote the release of sugars into the blood - something the drugs are supposed to prevent, Cambridge scientists have claimed.
Scroll Up
Scroll Down

Next Generation Sequencing Method for Illumina TruSeq DNA Sample Preparation Protocol on the Hamilton STAR
Bookmark and Share


Next Generation Sequencing (NGS) has accelerated the sequencing of genomes and this technology has a major role to play in the biomedical research. The simplicity of NGS library preparation, the ability to make these libraries from tiny input amounts of DNA, the elimination of a bacterial cloning intermediate and the development of data-analysis approaches to support the increasing size of the sequence datasets have been invaluable in the advancement of NGS. This application note describes the automation of the Illumina TruSeq DNA sample preparation on the Hamilton STAR . The data presented includes PicoGreen assay and Sybr E-Gel results for comparison of library construction using automated and manual methods, Bioanalyzer and KAPA assay results and data from Illumina HiSeq. Automation allowed processing 96 samples simultaneously in less than 4 hrs. Sample recovery yields higher by 50% were obtained with automated compared to manual method. The sample preparation provided average 80% reads on target from Illumina HiSeq.

Further Information

Related Content

Introduction of an Anti Droplet Control Pipette
HAMILTON introduces ADC, for pipetting volatile organic solvents, with pressure sensors in the pipetting channel to monitor each pipetting step.
Monday, December 11, 2006
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos